Neoadjuvant Sequencing

Neoadjuvant Sequencing is a strategic treatment protocol in oncology that refers to the administration of immunotherapeutic agents before surgical intervention to modulate the tumor microenvironment and enhance systemic immune responses, thereby distinguishing it from adjuvant approaches that follow surgery.

17

Publications

973

Citations

288

Authors

106

Institutions

Publications per year

2017–2026

10

Authors

288

  1. AP
    A. Prat

    Instituto Nacional de Enfermedades Neoplásicas, Peru

    1 publications · 27 citations

    1

    h-index

  2. QW
    Qun Wang

    Zhongshan Hospital, China

    1 publications · 12 citations

    1

    h-index

  3. PY
    Patrick Yu

    Nanostring Technologies (United States), United States

    1 publications · 413 citations

    1

    h-index

  4. MK
    Max Kates

    Johns Hopkins University, United States

    1 publications · 70 citations

    1

    h-index

  5. RM
    Richard M. Weinshilboum

    Mayo Clinic, United States

    1 publications · 83 citations

    1

    h-index

1–5 of 288

Venues

  1. Nature Genetics

    1 publications · 413 citations

    1

    h-index

  2. JNCI Journal of the National Cancer Institute

    1 publications · 83 citations

    1

    h-index

  3. European Urology

    1 publications · 70 citations

    1

    h-index

  4. PubMed

    Repository · 1 publications · 69 citations

    1

    h-index

  5. European Journal of Cancer

    1 publications · 67 citations

    1

    h-index

1–5